Clinical Trials Logo

Osteoarthritis clinical trials

View clinical trials related to Osteoarthritis.

Filter by:

NCT ID: NCT05337709 Recruiting - Pain Clinical Trials

Pharmacist Provided Intervention (Education and Medication Review) in Osteoarthritis

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to initiate pharmacist intervention (educational and medication review) among osteoarthritis patients visiting community pharmacies.

NCT ID: NCT05337540 Recruiting - Osteoarthritis Clinical Trials

A Study to Evaluate the Efficacy, Safety and Tolerability of EVI-01 Intra-Articular Injection in Osteoarthritis of the Knee

Start date: January 17, 2024
Phase: N/A
Study type: Interventional

Objective: Identifying the dose of EVI-01 with the best clinical response, balancing the efficacy, safety, and tolerability of the investigational product. Study design: Interventional, dose-finding, three arms, randomized (1:1:1), parallel assignment, double-blind, controlled by an active comparator.

NCT ID: NCT05335486 Withdrawn - Chronic Pain Clinical Trials

Investigating RELEARN Neurofeedback as Treatment for Chronic Musculoskeletal Pain

RELEARN
Start date: October 5, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

This clinical investigation will be carried out as a randomized controlled trial conducted at the Northern Regional Hospital, Hjørring. This investigation will enrol 36 patients suffering from severe knee osteoarthritis pain, primarily from the orthopaedic ward at Hjørring Hospital, where potential participants will be identified during routine consultations. The RELEARN intervention consists of encephalography (EEG) neurofeedback of cerebral movement evoked signatures of pain, where the participants will be instructed in attempting to manipulate these signatures to reduce pain perception. This investigation is carried out to analyse the clinical performance and safety of the RELEARN neurofeedback software.

NCT ID: NCT05334524 Completed - Knee Osteoarthritis Clinical Trials

Kinesiotaping With and Without Combined Chain Exercises in Patients With Knee Osteoarthritis

Start date: November 30, 2021
Phase: N/A
Study type: Interventional

Knee osteoarthritis is a major public health issue because it causes chronic pain, reduces physical function and diminishes quality of life. Aging of the population and increased global prevalence of obesity are anticipated to dramatically increase the prevalence of knee osteoarthritis. Knee osteoarthritis is characterized by complex multifactorial joint pathology and is the most common form of joint disorder in the world. Chronic knee osteoarthritis leads to marked weakening of the quadriceps femoris muscle, which is the extensor and stabilizer of the knee and atrophy of this muscle result knee pain and functional impairment. Quadriceps muscle weakness and atrophy have been reported to contribute to functional impairment and pain in patients with knee osteoarthritis and quadriceps strengthening can be achieved through open kinetic chain exercises and close kinetic chain exercises. Close kinetic chain exercises are modeled as, in which a movement in a joint simultaneously produces movements in other joints of the extremity. Open kinetic chain exercises and close kinetic chain exercises form the combined chain exercises. Kinesiotaping with these exercises to improve the patients suffering with knee osteoarthritis. The aim of this study will be to compare the effects of kinesiotaping as an adjunct to combined chain exercises compared with only kinesiotaping on pain, range of motion and quality of life in the management of individuals with knee osteoarthritis. This study will be randomized control trial. Patients will be recruited into two groups by simple random assignment. Non probability consecutive sampling technique will be used. Data will be collected from patients of grade 2 knee osteoarthritis patients by using NPRS for pain, Goniometer for ROM and SF-36 for quality of life will be used before and immediate after the treatment. Those who will meet the inclusion criteria will be recruited. Group 1 will be treated with kinesiotaping and combined chain exercises and the Group 2 will be treated with only kinesiotaping on knee OA patients. Total intervention will be given for four weeks for three sessions per week.The subject attended physical therapy and kinesiotaping will assess for pain, range of motion and quality of life at baseline and after 4 week of intervention. After collecting data from defined study setting, data will be entered and analyzed by using Statistical Package for the Social Sciences (SPSS) for Windows software, version 25.

NCT ID: NCT05330689 Withdrawn - Clinical trials for Osteoarthritis, Knee

How Does Platelet Dose Impact Clinical Outcomes After PRP Treatment?

Start date: March 6, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine which platelet rich plasma (PRP) injection dosage provides the most improvement in a patient's knee pain level at 26 weeks post-injection.

NCT ID: NCT05329116 Recruiting - Clinical trials for Osteo Arthritis Knee

Efficacy of Mesotherapy Added to Intra-articular Platelet-rich Plasma (PRP) in Patients With Knee Osteoarthritis

Start date: May 15, 2022
Phase: N/A
Study type: Interventional

In this study, the investigators aimed to determine whether platelet rich plasma (PRP) and mesotherapy combined treatment is effective on pain and function compared to PRP alone in patients with knee osteoarthritis (OA).

NCT ID: NCT05327413 Recruiting - Knee Osteoarthritis Clinical Trials

Femoral External Rotation Measured on CT and MRI

Start date: April 1, 2022
Phase:
Study type: Observational

This study aims to compare the femoral external rotation measured on CT and MRI to that measured intraoperatively to clarify the influence of residual cartilage on posterior condyle on the preoperative planning of total knee arthroplasty.

NCT ID: NCT05324163 Completed - KNEE OSTEOARTHRITIS Clinical Trials

Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis

Start date: September 29, 2021
Phase: Phase 3
Study type: Interventional

This study is a randomized, double-blind clinical trial in a Chinese population

NCT ID: NCT05322902 Completed - Knee Osteoarthritis Clinical Trials

Remimazolam Total Intravenous Anesthesia Under Analgesia Nociception Index-guidance

Start date: June 2, 2022
Phase: N/A
Study type: Interventional

The investigators hypothesized that intraoperative opioid consumption would be different between remimazolam and propofol if the ANI-guided remifentanil continuous infusion rate was adjusted when the depth of anesthesia was maintained at similar depths with remimazolam or propofol under total intravenous anesthesia. The purpose of this study is to compare the intraoperative remifentanil requirement in patients undergoing total knee arthroplasty when the intraoperative remifentanil dose adjustment was performed under the ANI guidance while maintaining a similar depth of anesthesia with remimazolam or propofol.

NCT ID: NCT05322681 Not yet recruiting - Osteoarthritis Clinical Trials

The Clinical Effect of Pregabalin on Neuropathic Pain in Non Central Sensitized Patients After Total Knee Arthroplasty

Start date: May 2022
Phase: N/A
Study type: Interventional

In this study, patients scheduled to undergo total knee arthroplasty (TKA) will be screened through a survey for patients without central sensitivity and patients with neuropathic pain as preoperative evaluation. It is designed to evaluate the effectiveness of pregabalin by dividing patient groups according to non central sensitization and neuropathic pain.